By SquaredTown on February 19, 2026
World-renowned immunologist strengthens scientific leadership and translational focus BOSTON, Feb. 19, 2026 /PRNewswire/ -- Vie Ventures, a life sciences venture capital firm focused on autoimmune and immune-mediated diseases, today announced that Jeff Bluestone, PhD, has been named...